基于全球注册数据库的EVAR术后瘤囊缩小预测因素
本研究利用GREAT注册数据库,纳入526例接受GORE EXCLUDER支架行EVAR且完成三年CTA随访的患者,分析瘤囊缩小百分比与基线及手术因素的关系。多因素回归显示,锥形瘤颈和较大的近端支架直径与更大幅度的瘤囊缩小独立相关,而高龄和较大的基线瘤囊直径则为负性预测因素。
要点
- 锥形瘤颈和较大近端支架直径与EVAR术后瘤囊缩小百分比增加独立相关。
- 高龄和较大基线瘤囊直径是瘤囊缩小的负性预测因素。
- 这些观察的临床效用及跨平台适用性仍需进一步研究。
核心结论
- 锥形瘤颈和较大近端支架直径与EVAR术后瘤囊缩小百分比增加相关,高龄和较大基线瘤囊直径为负性预测因素。
研究设计与样本
- 纳入526例(占3265例注册者的16.2%)在EVAR后连续三年每年均完成CTA随访的患者。
主要发现
- 总体瘤囊平均直径从58.0 mm(标准差10.4,范围34.2–100.0)降至49.3 mm(标准差14.1,范围0–140)。
- 瘤囊向装置直径缩小的平均百分比为28.2%(标准差39.0,范围-103.7–183.9)。
- 多因素logistic回归显示锥形瘤颈(OR=1.64,P=0.023)和较大近端装置直径(OR=1.09,P=0.023)与更大瘤囊缩小百分比显著相关。
- 高龄(OR=0.96,P=0.002)和较大基线瘤囊直径(OR=0.98,P=0.028)为瘤囊缩小的负性预测因素。
临床怎么用
- 对于锥形瘤颈或使用较大近端支架直径的EVAR患者,可预期更显著的瘤囊缩小。
- 高龄或基线瘤囊直径较大的患者,EVAR术后瘤囊缩小可能较差,需加强影像随访。
局限性
- 仅16.2%的注册患者完成连续三年CTA随访,可能存在选择偏倚。
- 结论基于GORE EXCLUDER单一平台,跨其他内移植物平台的适用性未验证。
- 瘤囊缩小百分比作为替代指标,其临床效用尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aneurysm sac remodeling is a complex multifactorial process with unknown factors influencing sac regression after endovascular aortic aneurysm repair (EVAR). We sought to identify factors associated with this process by analyzing data obtained from patients treated with the GORE EXCLUDER endovascular aneurysm repair (EVAR) endoprosthesis from December 2010 to October 2016 enrolled in the Global Registry for Endovascular Aortic Treatment (GREAT). METHODS: All patients enrolled in GREAT with three years CT angiography (CTA) follow-up in each of the three successive years after EVAR were included. The percentage of sac size reduction toward device diameter was calculated and used as a surrogate for sac regression with the formula used being: sac size reduction = ((AAA baseline diameter - AAA diameter at follow-up)/(AAA baseline diameter - device diameter))∗100. The cohort was divided into two groups in accordance with the percentage of aneurysm sac reduction at three years; one with the top quartile of patients and the other with the lowest three quartiles. Demographic and procedural variables were analyzed using univariate and regression modeling to determine factors predictive of sac regression. RESULTS: There were 3265 subjects enrolled with follow-up as of May 2018 of which 526 (16.2%) had three years of CTA surveillance. Overall aneurysm sac size decreased from a mean of 58.0 mm (Std Dev: 10.4, range: 34.2, 100.0) to a mean of 49.3 mm (Std Dev: 14.1, range: 0, 140) for a percentage reduction toward device diameter of a mean 28.2% (Std Dev: 39.0, range: -103.7, 183.9). On multivariate logistic regression model; two factors proved to be statistically significant contributors to a larger percentage reduction in aneurysm sac: a conical neck (odds ratio [OR] = 1.64, P-value = 0.023) and a larger proximal device diameter (OR = 1.09, P-value = 0.023). On the other hand, two factors were negative predictors of sac shrinkage, namely: old age (OR = 0.96, P-value = 0.002) and larger baseline aneurysm sac diameter (OR = 0.98, P-value = 0.028). CONCLUSIONS: Aneurysms with conical necks and larger proximal device neck diameters have an increased percentage change in sac size over time after EVAR. Older age and larger initial diameters of aneurysms were negatively associated with percentage change in sac size as well as sac regression. Further study is needed to determine the clinical utility of these observations and applicability across multiple endoprosthesis platforms.
引用
- Boutrous ML, Peterson BG, Smeds MR, et al. Predictors of Aneurysm Sac Shrinkage Utilizing a Global Registry. Ann Vasc Surg. 2020. PMID: 32889165. doi:10.1016/j.avsg.2020.08.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。